|
Targretin
Targretin
information and resources from the National Cancer Institute
Targretin
(Other name for: bexarotene)Targretin
(Other name for: bexarotene)
bexarotene gel
For the topical treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy.
Ligand Pharmaceuticals Jun 28 2000
bexarotene capsules
For the treatment by oral capsule of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy.
Ligand Pharmaceuticals Dec 29 1999
|
|
|
|
|
|
Ligand Announces Preliminary Unaudited Financial Results for 2005 Mar 17, 2006
PharmaLive.com (press release), Sales of Targretin(R) capsules increased to $5.6 million for the three months ended December 31, 2005 compared to $3.6 million for the same 2004 period. ...
Targretin
-->
|
